SMT201500214B - Nuova composizione farmaceutica per il trattamentodi infezioni fungine - Google Patents

Nuova composizione farmaceutica per il trattamentodi infezioni fungine

Info

Publication number
SMT201500214B
SMT201500214B SM201500214T SM201500214T SMT201500214B SM T201500214 B SMT201500214 B SM T201500214B SM 201500214 T SM201500214 T SM 201500214T SM 201500214 T SM201500214 T SM 201500214T SM T201500214 B SMT201500214 B SM T201500214B
Authority
SM
San Marino
Prior art keywords
pharmaceutical composition
fungal infections
new pharmaceutical
treating fungal
treating
Prior art date
Application number
SM201500214T
Other languages
English (en)
Italian (it)
Inventor
Ewa Karlsson
Sahar Feizollahi Ashkar
Peter Kaufmann
Original Assignee
Moberg Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201500214(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Moberg Pharma Ab filed Critical Moberg Pharma Ab
Publication of SMT201500214B publication Critical patent/SMT201500214B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SM201500214T 2013-03-15 2015-09-10 Nuova composizione farmaceutica per il trattamentodi infezioni fungine SMT201500214B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2013/050654 WO2014140507A1 (en) 2013-03-15 2013-03-15 Pharmaceutical composition for the treatment of fungal infections

Publications (1)

Publication Number Publication Date
SMT201500214B true SMT201500214B (it) 2015-10-30

Family

ID=48142011

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500214T SMT201500214B (it) 2013-03-15 2015-09-10 Nuova composizione farmaceutica per il trattamentodi infezioni fungine

Country Status (27)

Country Link
US (2) US8987330B2 (ar)
EP (1) EP2777689B1 (ar)
JP (1) JP6503303B2 (ar)
KR (1) KR101582448B1 (ar)
CN (2) CN104661639B (ar)
BR (1) BR112015022590B8 (ar)
CA (1) CA2883613C (ar)
CY (1) CY1116559T1 (ar)
DK (1) DK2777689T3 (ar)
ES (1) ES2543957T3 (ar)
HK (1) HK1208378A1 (ar)
HR (1) HRP20150823T1 (ar)
HU (1) HUE026887T2 (ar)
IL (1) IL241175B (ar)
ME (1) ME02199B (ar)
MX (1) MX2015012273A (ar)
MY (1) MY176291A (ar)
PH (1) PH12015502073A1 (ar)
PL (1) PL2777689T3 (ar)
PT (1) PT2777689E (ar)
RS (1) RS54131B1 (ar)
SA (1) SA515361162B1 (ar)
SG (1) SG11201505763QA (ar)
SI (1) SI2777689T1 (ar)
SM (1) SMT201500214B (ar)
WO (2) WO2014140507A1 (ar)
ZA (1) ZA201505343B (ar)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014140507A1 (en) 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections
KR101599260B1 (ko) * 2015-07-30 2016-03-03 (주)우신메딕스 조갑진균증의 예방 또는 치료용 약학 조성물 및 이의 제조방법
ITUB20153759A1 (it) * 2015-09-21 2017-03-21 Federica Livieri Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
US10251858B1 (en) 2016-08-08 2019-04-09 Marlinz Pharma, LLC Composition for treating fungal infections in nails
US10543276B2 (en) 2016-08-08 2020-01-28 Marlinz Pharma, LLC Topical compositions
GB2554101B (en) * 2016-09-20 2021-05-05 Insense Ltd Composition for the treatment of a fungal infection
US20190151214A1 (en) * 2017-11-21 2019-05-23 Topix Pharmaceuticals, Inc. Methods and compositions for treatment of skin
KR20210107043A (ko) * 2018-12-19 2021-08-31 말린즈 파마 엘엘씨 국소 조성물
US20240238227A1 (en) 2023-01-12 2024-07-18 Wooshin Labottach Co., Ltd. Pharmaceutical composition for preventing or treating onychomycosis and preparation method therefor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296130A (en) 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
US4672078A (en) 1985-07-03 1987-06-09 Schering-Plough Corporation Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
SE462139B (sv) 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3820805B2 (ja) 1999-07-08 2006-09-13 株式会社ノエビア 皮膚外用剤
JP2003095914A (ja) * 2001-09-21 2003-04-03 Toyo Beauty Kk 尿素含有外用剤
US6986896B2 (en) * 2002-03-20 2006-01-17 Bradley Pharmaceuticals, Inc. Method of treating fungal conditions of the skin
US6573301B1 (en) 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
US8158138B1 (en) * 2004-05-20 2012-04-17 Fougera Pharmaceuticals, Inc. Urea compositions and their methods of manufacture
JP4972895B2 (ja) * 2005-08-29 2012-07-11 大正製薬株式会社 尿素配合外用製剤
US8435500B2 (en) 2005-11-01 2013-05-07 L'oréal Nail whitening composition
AU2010283031A1 (en) 2009-08-13 2012-01-19 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail
WO2012110430A1 (en) * 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
WO2014140507A1 (en) 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections

Also Published As

Publication number Publication date
IL241175B (en) 2019-10-31
EP2777689A1 (en) 2014-09-17
IL241175A0 (en) 2015-11-30
PT2777689E (pt) 2015-09-11
US20150306052A1 (en) 2015-10-29
SI2777689T1 (sl) 2015-08-31
ES2543957T3 (es) 2015-08-26
PH12015502073B1 (en) 2016-01-25
ZA201505343B (en) 2017-06-28
JP6503303B2 (ja) 2019-04-17
DK2777689T3 (da) 2015-06-22
HUE026887T2 (en) 2016-07-28
CY1116559T1 (el) 2017-03-15
PL2777689T3 (pl) 2015-10-30
RS54131B1 (en) 2015-12-31
JP2016514121A (ja) 2016-05-19
US8987330B2 (en) 2015-03-24
CN109394743A (zh) 2019-03-01
EP2777689B1 (en) 2015-05-27
SA515361162B1 (ar) 2016-11-09
HRP20150823T1 (hr) 2015-09-11
CA2883613C (en) 2016-04-12
CN104661639A (zh) 2015-05-27
KR20150054824A (ko) 2015-05-20
MY176291A (en) 2020-07-27
US9782372B2 (en) 2017-10-10
PH12015502073A1 (en) 2016-01-25
WO2014140524A1 (en) 2014-09-18
BR112015022590A2 (pt) 2017-07-18
ME02199B (me) 2016-02-20
HK1208378A1 (en) 2016-03-04
CA2883613A1 (en) 2014-09-18
CN104661639B (zh) 2019-06-28
SG11201505763QA (en) 2015-08-28
WO2014140507A1 (en) 2014-09-18
KR101582448B1 (ko) 2016-01-04
BR112015022590B8 (pt) 2023-03-21
BR112015022590B1 (pt) 2020-08-25
MX2015012273A (es) 2016-01-25
US20140275254A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
FR21C1059I2 (fr) Compositions pharmaceutiques
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3060041T3 (da) Prostacyclinforbindelser
DK2943549T3 (da) Synergistisk h2s-scavenger-sammensætning
DK2988791T3 (da) Tværbundet silke-hyaluronsyresammensætning
BR112016011065A2 (pt) Composto cristalino, composição farmacêutica, forma de dosagem, método para tratar anemia
SMT201500214B (it) Nuova composizione farmaceutica per il trattamentodi infezioni fungine
BR112016010669A2 (pt) composição desinfetante
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
DK3027750T3 (da) Biokatalytisk sammensætning
HK1213182A1 (zh) 外用藥物組合物
DE112014002420A5 (de) Kondensator
FR3001392B1 (fr) Composition dermatologique amelioree
SG11201601477VA (en) Pharmaceutical composition
GB201320932D0 (en) Topical pharmaceutical composition
DK3079667T3 (da) Farmaceutiske doseringsformer
BR112016021875A2 (pt) composição tópica
DK3003401T3 (da) Farmaceutisk præparat
HK1223038A1 (zh) 抗病毒有效的藥物組合物
HK1220143A1 (zh) 藥物組合物
DK3060213T3 (da) Farmaceutiske sammensætninger omfattende antibakterielle midler
MA42111A (fr) Compositions pharmaceutiques topiques
DK3082855T3 (da) Sammensætning
TH1401007606A (th) องค์ประกอบต้านจุลชีพ
TH1501000622A (th) องค์ประกอบแชมพู